GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » Short-Term Capital Lease Obligation

BioTech Medics (BioTech Medics) Short-Term Capital Lease Obligation : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTech Medics Short-Term Capital Lease Obligation?

BioTech Medics's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil.


BioTech Medics Short-Term Capital Lease Obligation Historical Data

The historical data trend for BioTech Medics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics Short-Term Capital Lease Obligation Chart

BioTech Medics Annual Data
Trend
Short-Term Capital Lease Obligation

BioTech Medics Quarterly Data
Short-Term Capital Lease Obligation

BioTech Medics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


BioTech Medics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioTech Medics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTech Medics (BioTech Medics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.